Avital Lev PhD

Cancer Discovery

Dr. Lev works at the American Association for Cancer Research as an Associate Editor at Cancer Discovery. She received her PhD from the Technion – Israel Institute of Technology and completed a postdoctoral fellowship there, developing a new strategy to construct molecules that enhance T-cell cytotoxicity against cancer cells. She continued her research at the NIH and at Fox Chase Cancer Center, where she conducted research in viral immunology and later has been involved in the development of small-molecule drugs for colorectal, prostate, and pancreatic cancer. At Cancer Discovery she is involved in publishing articles describing major advances in basic, translational, and clinical research in the field of oncology.